Related Experiment Videos
Radiolabeled amino acids: basic aspects and clinical applications in oncology
P L Jager1, W Vaalburg, J Pruim
1Department of Nuclear Medicine, PET Center, University Hospital Groningen, Groningen, The Netherlands.
Summary
Radiolabeled amino acid imaging shows promise for diagnosing various tumors, particularly brain tumors. While advantageous over (18)F-FDG PET imaging due to less inflammation influence, further research is needed for broader clinical application.
Area of Science:
- Nuclear Medicine
- Oncology
- Radiochemistry
Background:
- Metabolic imaging applications are expanding, increasing interest in radiolabeled amino acids.
- Amino acid metabolism and radiolabeled amino acid principles are fundamental to understanding their diagnostic utility.
Purpose of the Study:
- To review the basic aspects of amino acid metabolism and radiolabeled amino acids.
- To describe clinical applications of radiolabeled amino acids, focusing on diagnostic value, especially for brain tumors.
Main Methods:
- Review of existing literature on amino acid metabolism, radiolabeled amino acids, and clinical applications.
- Focus on specific radiotracers like (11)C-methionine, (11)C-tyrosine, and (123)I-iodomethyltyrosine.
Main Results:
- Amino acid imaging demonstrates sound theoretical and preclinical background, supporting clinical use.
- Less influenced by inflammation compared to (18)F-FDG PET, offering potential advantages.
- Established diagnostic accuracy and advantageous value in brain tumor imaging.
- Feasibility shown in other tumor types, but requires further research in larger cohorts.
Conclusions:
- Radiolabeled amino acid imaging is a valuable tool, particularly for brain tumors, with established diagnostic accuracy.
- While showing promise and advantages over other methods, broader application requires further investigation in diverse clinical settings and larger patient groups.